State of the Union: Transcatheter Aortic Valve Interventions
Presenter
David A. Wood, M.D., UBC Centre for Cardiovascular Innovation, Vancouver, BC, CANADA
David A. Wood, M.D., UBC Centre for Cardiovascular Innovation, Vancouver, BC, CANADA
Learning Objectives:
- Review 2025 key trials and data on TAVR durability (e.g., 10–15-year outcomes showing improved EOA and reduced degeneration) and procedural refinements like commissural alignment.
- Discuss challenges in younger patients and bicuspid valves, with real-world registry insights on coronary access and redo interventions.
- Glimpse into the future: Emerging PCSK9 inhibitors, tissue-engineered valves, and imaging like 18F-NaF PET/CT for early calcification detection to enable preventive strategies.